Tuesday, January 16, 2018

Aerie Pharmaceuticals Names VPs

Irvine-based Aerie Pharmacueticals said this morning that it has named two new executives. According to the developer of glaucoma therapies, it has named Nils Hauptmann as Director of Regulatory Affairs and Pharmacovigilance and Tim Swan as Director of Sales and Transparency Operations. Hauptmann was previously at Avanir Pharmaceuticals and Fibrogen. Swan was previously at Allergan.